Leadership Team
Anders Rylander
- CEO since 2011
Anders Morén
- CFO since 2023
Hanna Ritzén
- SVP Global Marketing and Business Development, since 2022
Henrik Winther
- SVP Business Development since 2020
Hector Tamburini
- Head of US Operations since 2024
Rickard Boman
- VP R&D and Production, since 2025
Sofia Löhman
- VP QA/RA since 2025
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects